Abree Johnson, MS, MBA

Director, Pharmaceutical Research Computing
University of Maryland Baltimore
Baltimore, United States

Disclosure information not submitted.

Presentation(s):

• Longitudinal Treatment Pathways Following Opioid Use Disorder Diagnosis Among Commercially-Insured Beneficiaries in the U.S.

  Monday, August 26, 2024
  2:00 PM – 2:15 PM CEST